A dialysis facility in FL. It ran an operating surplus of 20.1% in FY22 on $1.8M of operating revenue. It held 45 days of cash on hand (52nd percentile among dialysis facilities on liquidity). Operating margin improved from 13.3% in FY20 to 20.1% in FY22, though it fell 2.2 points in the most recent year.
Operating margin · FY22
+20.1%
▼ 2.2 pts vs FY21
vs dialysis facilities69th pctl of 7,741
Days cash on hand · FY22
45d
all sources
▲ 17.3 days vs FY21
vs dialysis facilities52nd pctl
Total operating revenue · FY22
$1.8M
▼ 1.4 $M vs FY21
vs dialysis facilities24th pctl
Total margin · incl. nonoperating · FY22
+20.1%
▼ 2.5 pts vs FY21
vs dialysis facilities72nd pctl
Where DIALYSIS 682515 sits among dialysis facilities
Operating margin · FY22 pool · n = 7,741 of 7,741 filed
Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.
One dialysis facilityDIALYSIS 682515dialysis facility median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
+20.1% (FY22)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+20.1% (FY22)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
45d (FY22)
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
1.41× (FY22)
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
41% (FY22)
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
75d (FY22)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line item
FY20
FY21
FY22
Patient revenue
3,147
3,247
1,817
Total operating revenue
3,147
3,247
1,817
Total operating expenses
2,730
2,521
1,452
Operating income
418
725
365
Operating margin %
+13.3%
+22.3%
+20.1%
Other non-operating, net
0
10
0
Net income
418
735
365
Net income %
+13.3%
+22.6%
+20.1%
HCRIS CMS-265 cost report · $ thousands · FY20–FY22 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
How it operates
quality & operational context · CMS public reporting
The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.
Total treatments
6,395
Verified fact2022
HCRIS CMS-265
Cost per treatment ($)
226.98
Verified fact2022
HCRIS CMS-265
Net revenue per treatment ($)
284.09
Verified fact2022
HCRIS CMS-265
Trajectory
Cost-report basis · 3 reporting years
Operating margin
Days cash on hand
The county this dialysis facility serves
Location, FL
Median household income
$52.3K
vs $82.1K US · $59.7K rural median
Poverty rate
19.0%
vs 12.5% US · 14.3% rural median
Uninsured
17.3%
vs 8.6% US · 8.4% rural median
Age 65+
20.1%
vs 16.8% US · 20.6% rural median
Fair or poor health
27.3%
self-reported, adults · CDC PLACES
Primary-care shortage
Designated
HRSA HPSA
Economic context: 15.4% of county personal income is Medicare/Medicaid medical benefits; 33.5% arrives as government transfers (BEA, 2022).
The Board Briefing$1,000
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
